InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Hubbard John W, 董事. Director active across 2 companies, notably Agile Therapeutics INC. Cumulatively, 6 filings have been recorded. Activity tracked since 8 June 2021. The latest transaction was disclosed on 26 August 2024 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
John W. Hubbard is a Director at Agile Therapeutics Inc, a biopharmaceutical company. In this role, he participates in the governance of the company and the development of its strategy. Hubbard brings valuable expertise in healthcare, allowing him to play an active role in strategic decision-making. His commitment to innovation and improving healthcare is central to his mission on the board.